{"id":"NCT02165397","sponsor":"Pharmacyclics LLC.","briefTitle":"Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia","officialTitle":"iNNOVATE Study: A Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study of Ibrutinib or Placebo in Combination With Rituximab in Subjects With Waldenström's Macroglobulinemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07-07","primaryCompletion":"2019-11-07","completion":"2019-11-07","firstPosted":"2014-06-17","resultsPosted":"2020-11-16","lastUpdate":"2021-03-03"},"enrollment":181,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Waldenström's Macroglobulinemia"],"interventions":[{"type":"DRUG","name":"Ibrutinib","otherNames":["PCI-32765"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Rituximab","otherNames":["Rituxan"]}],"arms":[{"label":"Randomized Study (Ibrutinib + Rituximab)","type":"EXPERIMENTAL"},{"label":"Randomized Study (Placebo + Rituximab)","type":"EXPERIMENTAL"},{"label":"Open-Label Substudy (Ibrutinib)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of ibrutinib in combination with rituximab in participants with Waldenström's macroglobulinemia (WM).","primaryOutcome":{"measure":"Progression Free Survival (PFS) Based on Independent Review Committee (IRC) Assessment - Kaplan Meier Landmark Estimates at Month 54","timeFrame":"Month 54 (median time on study: 49.7 months [Ibr+R and Pbo+R] and 57.9 months [Open-Label Ibr])","effectByArm":[{"arm":"Ibrutinib + Rituximab","deltaMin":68,"sd":null},{"arm":"Placebo + Rituximab","deltaMin":25.3,"sd":null},{"arm":"Open-Label Substudy: Ibrutinib","deltaMin":39.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":48,"countries":["United States","Australia","Canada","France","Germany","Greece","Italy","Spain","United Kingdom"]},"refs":{"pmids":["29856685","27956157","36815271","34606378","34380643"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":75},"commonTop":["Infusion related reaction","Diarrhoea","Anaemia","Tumour flare","Headache"]}}